AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 65 filers reported holding AMRYT PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 0 | – | 0.00% | – |
| Q2 2023 | $0 | – | 0 | – | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $3,687 | -99.9% | 505,000 | 0.0% | 1.62% | -8.5% |
| Q3 2022 | $3,495,000 | +15.0% | 505,000 | +16.1% | 1.77% | +25.1% |
| Q2 2022 | $3,040,000 | -15.5% | 435,000 | 0.0% | 1.42% | +1.8% |
| Q1 2022 | $3,597,000 | -23.4% | 435,000 | 0.0% | 1.39% | -21.6% |
| Q4 2021 | $4,698,000 | -4.9% | 435,000 | +6.1% | 1.77% | -50.8% |
| Q3 2021 | $4,938,000 | +29.2% | 410,000 | +30.2% | 3.60% | +24.8% |
| Q2 2021 | $3,821,000 | +119.5% | 315,000 | +152.0% | 2.89% | +92.4% |
| Q1 2021 | $1,741,000 | -1.6% | 125,000 | 0.0% | 1.50% | -12.7% |
| Q4 2020 | $1,770,000 | +14.6% | 125,000 | 0.0% | 1.72% | -24.6% |
| Q3 2020 | $1,545,000 | – | 125,000 | – | 2.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |